Integration of transcriptomics, proteomics and metabolomics identifies biomarkers for pulmonary injury by polyhexamethylene guanidine phosphate (PHMG-p), a humidifier disinfectant, in rats

Jung Dae Lee,Hyang Yeon Kim,Keunsoo Kang,Hye Gwang Jeong,Mi-Kyung Song,In Hwan Tae,Su Hyun Lee,Hae Ri Kim,Kyuhong Lee,Sehyun Chae,Daehee Hwang,Suhkmann Kim,Hyung Sik Kim,Kyu-Bong Kim,Byung-Mu Lee

DOI: https://doi.org/10.1007/s00204-020-02657-x

2020-02-20

Archives of Toxicology

Abstract:Polyhexamethylene guanidine phosphate (PHMG-p) was used as a humidifier disinfectant in Korea. PHMG induced severe pulmonary fibrosis in Koreans. The objective of this study was to elucidate mechanism of pulmonary toxicity caused by PHMG-p in rats using multi-omics analysis. Wistar rats were intratracheally instilled with PHMG-p by single (1.5 mg/kg) administration or 4-week (0.1 mg/kg, 2 times/week) repeated administration. Histopathologic examination was performed with hematoxylin and eosin staining. Alveolar macrophage aggregation and granulomatous inflammation were observed in rats treated with single dose of PHMG-p. Pulmonary fibrosis, chronic inflammation, bronchiol–alveolar fibrosis, and metaplasia of squamous cell were observed in repeated dose group. Next generation sequencing (NGS) was performed for transcriptome profiling after mRNA isolation from bronchiol–alveoli. Bronchiol–alveoli proteomic profiling was performed using an Orbitrap Q-exactive mass spectrometer. Serum and urinary metabolites were determined using 1H-NMR. Among 418 differentially expressed genes (DEGs) and 67 differentially expressed proteins (DEPs), changes of 16 mRNA levels were significantly correlated with changes of their protein levels in both single and repeated dose groups. Remarkable biological processes represented by both DEGs and DEPs were defense response, inflammatory response, response to stress, and immune response. Arginase 1 (Arg1) and lipocalin 2 (Lcn2) were identified to be major regulators for PHMG-p-induced pulmonary toxicity based on merged analysis using DEGs and DEPs. In metabolomics study, 52 metabolites (VIP > 0.5) were determined in serum and urine of single and repeated-dose groups. Glutamate and choline were selected as major metabolites. They were found to be major factors affecting inflammatory response in association with DEGs and DEPs. Arg1 and Lcn2 were suggested to be major gene and protein related to pulmonary damage by PHMG-p while serum or urinary glutamate and choline were endogenous metabolites related to pulmonary damage by PHMG-p.

toxicology

What problem does this paper attempt to address?

This paper aims to explore the pulmonary toxicity mechanism caused by polyhexamethylene guanidine phosphate (PHMG - p). PHMG - p was once used as a humidifier disinfectant in South Korea, resulting in severe pulmonary fibrosis. The study uses multi - omics analysis (transcriptomics, proteomics and metabolomics) to identify biomarkers of lung injury caused by PHMG - p in rats.

### Research Background
- **PHMG - p**: A water - soluble chemical substance, commonly used as a disinfectant in hospitals and residential facilities, and is widely used because of its low toxicity.
- **Pulmonary Diseases**: After entering the human body through humidifier spray, PHMG - p causes severe pulmonary inflammation and fibrosis, and even leads to death.
- **Research Purpose**: Through multi - omics analysis, reveal the molecular mechanism of pulmonary toxicity caused by PHMG - p and develop relevant biomarkers.

### Methods
- **Animal Experiments**: Use Wistar rats and perform single - dose (1.5 mg/kg) and multiple - dose (0.1 mg/kg, twice a week for 4 weeks) intratracheal administrations respectively.
- **Histopathological Examination**: Observe the pathological changes of lung tissues by hematoxylin - eosin staining.
- **Transcriptomics Analysis**: Use high - throughput sequencing technology (NGS) to analyze the expression profile of mRNA in broncho - alveolar tissues.
- **Proteomics Analysis**: Use Orbitrap Q - exactive mass spectrometer to analyze proteins in broncho - alveolar tissues.
- **Metabolomics Analysis**: Use 1H - NMR technology to determine metabolites in serum and urine.

### Results
- **Histopathology**: Alveolar macrophage aggregation and granulomatous inflammation were observed in the single - dose group; pulmonary fibrosis, chronic inflammation, broncho - alveolar fibrosis and squamous cell metaplasia were observed in the multiple - dose group.
- **Transcriptomics**: 418 differentially expressed genes (DEGs) were identified, among which the changes in 16 mRNA levels were significantly correlated with their protein levels.
- **Proteomics**: 67 differentially expressed proteins (DEPs) were identified, among which the changes in 16 protein levels were significantly correlated with mRNA levels.
- **Metabolomics**: 52 metabolites (VIP > 0.5) were identified, and glutamate and choline were selected as the main metabolites, which are related to the inflammatory response.
- **Major Regulatory Factors**: Through the integration of DEGs and DEPs analysis, arginase 1 (Arg1) and lipocalin 2 (Lcn2) were identified as major regulatory factors.

### Conclusions
- **Biomarkers**: Arg1 and Lcn2 are considered as the major genes and proteins of lung injury caused by PHMG - p, and glutamate and choline in serum or urine are endogenous metabolites related to lung injury.
- **Mechanism**: PHMG - p causes lung injury by inducing inflammatory response and fibrosis changes.

This study provides important molecular - level evidence for understanding the pulmonary toxicity mechanism caused by PHMG - p, and provides potential biomarkers for future diagnosis and treatment.